Diabetes News and Research

Latest Diabetes News and Research

Scientists link human gene to risk of developing Mild Cognitive Impairment

Connecting a human gene to the risk of developing the Alzheimer's precondition known as Mild Cognitive Impairment has been somewhat of a holy grail for scientists, but a team led by researchers from Cornell University has ended the quest.

14 Jul 2011

Researchers capitalize on 'memories' of adult-derived stem cells for treatment of diabetes

Stem cells from early embryos can be coaxed into becoming a diverse array of specialized cells to revive and repair different areas of the body. Therapies based on these stem cells have long been contemplated for the treatment of diabetes, but have been held back by medical and ethical drawbacks.

14 Jul 2011

Roundup: N.H.'s Planned Parenthood funding dilemma; Calif. prison doc's high pay, little work

The highest-paid state employee in California last year, a prison surgeon who took home $777,423, has a history of mental illness, was fired once for alleged incompetence and has not been allowed to treat an inmate for six years because medical supervisors don't trust his clinical skills. Since July 2005, Dr. Jeffrey Rohlfing has mostly been locked out of his job — on paid leave or fired or fighting his termination — at High Desert State Prison in Susanville, state records show.

14 Jul 2011

Arabidopsis thaliana helps scientists to solve puzzles in human health

A tiny plant called Arabidopsis thaliana just helped scientists unearth new clues about the daily cycles of many organisms, including humans. This is the latest in a long line of research, much of it supported by the National Institutes of Health, that uses plants to solve puzzles in human health.

14 Jul 2011

DARA's DB959 shows promise against type 2 diabetes

A new peroxisome proliferator activated receptor agonist currently in development, DB959, will most likely be administered orally once a day, according to a presentation made by researchers recently at the American Diabetes Association's 71st Scientific Sessions.

14 Jul 2011

New ‘state-by-state’ obesity data released in U.S.

A new report called ‘F as in Fat: How Obesity Threatens America's Future 2011’ from the Trust for America’s Health and the Robert Wood Johnson Foundation, shows that Massachusetts has one of the lowest obesity rates in the nation even as obesity rises across the Bay State.

14 Jul 2011

Patient-centered medical home boosts diabetes outcomes, health

A health-care delivery model called patient-centered medical home (PCMH) increased the percentage of diabetes patients who achieved goals that reduced their sickness and death rates, according to health researchers.

14 Jul 2011

Variation in DNA sequence linked to increased risk of sudden cardiac death

In a large and comprehensive investigation into the underlying causes of sudden cardiac death (SCD) - a surreptitious killer of hundreds of thousands annually in the United States - researchers have discovered a variation in the genome's DNA sequence that is linked to a significant increase in a person's risk of SCD.

13 Jul 2011

Kinexus introduces new KiNET-Antibody Microarray website

Kinexus Bioinformatics Corporation, a world-leader in molecular intelligence research, announced a major expansion in its KiNET DataBank for the study of cell communication systems with the launch of the KiNET-Antibody Microarray website.

13 Jul 2011

WHO releases 2011 global status report on alcohol and health

The World Health Organization (WHO) has released its global status report on alcohol and health for 2011. Forum members largely agree with the discussion in the report of the serious health and societal problems associated with the misuse of alcohol, which contributes to accidents, many diseases, and premature deaths.

13 Jul 2011

USFDA approves Dr. Reddy's ANDA for Fondaparinux Sodium Injection

Dr. Reddy's Laboratories and Alchemia Limited, Brisbane, Australia announced today that Dr. Reddy's has received final approval of Dr. Reddy's ANDA for Fondaparinux Sodium Injection, a bioequivalent generic version of Arixtra, in the US market on July 11, 2011 by the United States Food & Drug Administration.

13 Jul 2011

Study: Modified fat diet might reduce risk of heart disease

The debate between good fat versus bad fat continues, as a new evidence review finds that a modified fat diet — and not a low fat diet — might be the real key to reducing one's risk of heart disease.

13 Jul 2011

Study looks at fresh food access and influence on eating habits

According to a new U.S. study living closer to supermarkets and grocery stores did not mean that urban dwellers ate more fruits and vegetables, or had a healthier overall diet. On the other hand having more fast-food restaurants nearby did mean that low-income men ate at the chain restaurants more often. The study was published in the Archives of Internal Medicine.

13 Jul 2011

Severely obese children should be removed from parents, placed in care: Expert opinion

In a controversial new opinion piece in the Journal of the American Medical Association the authors suggest taking severely obese children out of their homes and placing them in foster care. Dr. David Ludwig, an obesity specialist at Harvard-affiliated Children’s Hospital Boston and Lindsey Murtagh, a lawyer and a researcher at Harvard’s School of Public Health, write that in some cases it may be justified to take an extremely obese child out of their parents’ custody.

13 Jul 2011

Eating nuts daily could help control type 2 diabetes and prevent complications

Eating nuts every day could help control Type 2 diabetes and prevent its complications, according to new research from St. Michael's Hospital and the University of Toronto.

13 Jul 2011

FDA clears St. Jude Medical's Epiducer lead delivery system for neurostimulation

St. Jude Medical, Inc., a global medical device company, today announced the U.S. Food and Drug Administration (FDA) clearance and limited market release of the Epiducer lead delivery system for neurostimulation therapy.

13 Jul 2011

Positive results from sarilumab Phase 2b trial on RA, ankylosing spondylitis

Sanofi and Regeneron Pharmaceuticals, Inc. announced results from Phase 2b trials in rheumatoid arthritis (RA) and ankylosing spondylitis (AS) with sarilumab, a novel, high-affinity, subcutaneously administered, fully-human antibody targeting the interleukin-6 receptor.

13 Jul 2011

New animal model for studying development of testicular germ cell tumors

A team of researchers from Spain and Switzerland have developed a new model for studying the development of testicular germ cell tumors by transplanting embryonic stem cells into the seminiferous tubules in mouse models, resulting in the development of testicular germ cell tumors (TGCT) that mimic the early stages of TGCT development.

12 Jul 2011

$More patients tested, treated when fracture clinics have someone dedicated to screening$

More patients tested, treated when fracture clinics have someone dedicated to screening

More patients are tested and treated for osteoporosis when fracture clinics have someone dedicated to screening for the bone disease, a new study has found.

12 Jul 2011

Two papers highlight therapeutic potential of human Sertoli cells

Two papers published in the current issue of Cell Transplantation, now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/, highlight the therapeutic potential of human Sertoli cells that are present in the testes and are also called "nurse" or "mother" cells because they nurture the developing sperm cells.

12 Jul 2011